Lithium Controlled-Release and Extended-Release Tablets and Metreleptin Subcutaneous
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Metreleptin Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: metreleptin
Brand name: Myalept
Synonyms: Metreleptin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-MetroCream
- Lithium Controlled-Release and Extended-Release Tablets-Metrocream Topical
- Lithium Controlled-Release and Extended-Release Tablets-MetroGel
- Lithium Controlled-Release and Extended-Release Tablets-MetroGel (Metronidazole Cream, Gel, and Lotion)
- Lithium Controlled-Release and Extended-Release Tablets-MetroGel (Metronidazole Gel and Cleansing Lotion)
- Lithium Controlled-Release and Extended-Release Tablets-MetroGel Pump
- Metreleptin Subcutaneous-Lithium ER
- Metreleptin Subcutaneous-Lithium Oral Solution
- Metreleptin Subcutaneous-Lithium Salts
- Metreleptin Subcutaneous-Lithium Syrup and Oral Solution
- Metreleptin Subcutaneous-Lithobid
- Metreleptin Subcutaneous-Lithostat